世界食品網

歐盟評估擴展使用轉基因米曲霉菌株AR-183生產的內切多聚半乳糖醛酸酶的安全性

   2024-04-08 食品伙伴網澤夕1592
核心提示:2024年4月5日,歐盟食品安全局就一種食品酶內切多聚半乳糖醛酸酶(endo-polygalacturonase)的安全性評價發布意見。……(世界食品網-www.cctv1204.com)
     2024年4月5日,歐盟食品安全局就一種食品酶內切多聚半乳糖醛酸酶(endo-polygalacturonase)的安全性評價發布意見。 
  據了解,這種食品酶是由轉基因米曲霉菌株AR-183生產的,旨在用于七種食品生產過程。
 
  經過評估,專家小組得出結論,這種食品酶在預期使用條件下不會引起安全問題。部分原文報道如下:
 
  The food enzyme endo-polygalacturonase ((1?→?4)-α-d-galacturonan glycanohydrolase EC 3.2.1.15) is produced with the genetically modified Aspergillus oryzae strain AR-183 by AB ENZYMES GmbH. A safety evaluation of this food enzyme was made previously, in which EFSA concluded that this food enzyme did not give rise to safety concerns when used in five food manufacturing processes. Subsequently, the applicant requested to extend its use to two additional processes. In this assessment, EFSA updated the safety evaluation of this food enzyme for use in a total of seven food manufacturing processes. As the food enzyme-total organic solids (TOS) is removed from the final foods in three food manufacturing processes, the dietary exposure to the food enzyme-TOS was estimated only for the remaining four processes. Dietary exposure was up to 0.087 mg TOS/kg body weight (bw) per day in European populations. When combined with the NOAEL reported in the previous opinion (1000 mg TOS/kg bw per day, the highest dose tested), the Panel derived a margin of exposure of at least 11,494. based on the data provided for the previous evaluation and the revised margin of exposure, the Panel concluded that this food enzyme does not give rise to safety concerns under the revised intended conditions of use.
 
 
地區: 歐盟
反對 0舉報 0 收藏 0 打賞 0評論 0
 
更多>同類資訊
 
鹽池灘羊